Drug Type Small molecule drug |
Synonyms GPR68 (OGR1) negative allosteric modulator(Cumulus Oncology) |
Target |
Action modulators |
Mechanism GPR68 modulators(G protein-coupled receptor 68 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Colitis, Ulcerative | Preclinical | Switzerland | 18 Feb 2026 | |
| Colitis, Ulcerative | Preclinical | United Kingdom | 18 Feb 2026 | |
| Fibrosis | Preclinical | Switzerland | 01 Nov 2025 | |
| Fibrosis | Preclinical | United Kingdom | 01 Nov 2025 | |
| Inflammation | Preclinical | Switzerland | 20 Aug 2024 | |
| Inflammation | Preclinical | Switzerland | 20 Aug 2024 | |
| Neoplasms | Preclinical | Switzerland | 20 Aug 2024 | |
| Neoplasms | Preclinical | Switzerland | 20 Aug 2024 |





